About 30% of you carry a gene that raises your risk of Alzheimer's. A study published this year suggests the diet many of you were told to follow may be working against that gene rather than with it.
I'm Dr. Andrew Hill. I've spent 25 years in EEG and mental health, mapped more than 25,000 brains, and taught gerontology at UCLA for about a decade. This particular study caught my attention because it works at the population level, the kind of epidemiology that turns a vague worry about diet into a genotype-specific recommendation. Let me walk you through what it found, the mechanism underneath it, and what you can actually do.
What did the new APOE4 and meat study find?
Norrén and colleagues at Karolinska published in JAMA Network Open this year. The team followed roughly 2,100 Swedish adults age 60 and older for about 15 years. They tracked diet, APOE genotype, and cognitive outcomes, then adjusted the statistics for age, sex, education, and lifestyle.
Here is the result. Among people with low meat intake, carriers of APOE 3/4 or 4/4 had about twice the dementia risk of non-carriers. That tracks with what we already know about the gene. Then the researchers split the sample into low-meat and high-meat halves. In the high-meat group, eating roughly 870 grams per week (about 30 ounces), the excess risk tied to APOE4 disappeared in the statistics. Carriers in the highest meat-intake group looked like non-carriers.
Two details make this worth your attention. The effect was genotype-specific: higher meat intake only helped people who carried at least one copy of APOE4. People with APOE 2 or 3 showed no benefit. And the benefit was limited to unprocessed meat. When the same dataset isolated processed meat, the protection went away.
This is one observational cohort. The authors themselves are calling for clinical trials. The interaction is specific, biologically plausible, and consistent with mechanisms we have understood for a while without fully connecting them.
What is APOE4 and why does it matter for Alzheimer's?
APOE is apolipoprotein E. The gene codes for a molecule involved in lipid transport, moving cholesterol and other fats around the body. Humans carry three variants: APOE2, APOE3, and APOE4. You inherit two copies, which is why a genetic test reports your status as two numbers. A 3/4 means one copy of each. A 4/4 means two copies of the four.
Most people carry some version of a 3. APOE4 shows up in at least 30% of the population. If you are homozygous (two copies, 4/4), your Alzheimer's risk runs roughly 8 to 12 times the background rate depending on the study. Among people who develop Alzheimer's, about 70% carry at least one copy of APOE4.
The gene is probabilistic. The prevailing mechanistic story involves oxidative stress: sugars in an APOE4 brain appear to rust faster, generating more damage, more amyloid breakdown, more plaques and tangles. Blood sugar handling is part of the picture, and the full story is genuinely complex.
A quick note on the other variants, because the contrast is informative. APOE 2/2 is neuroprotective against Alzheimer's, with less amyloid beta and about 20% lower cardiovascular risk than a typical 3 carrier. The catch: homozygous APOE2 is rare (about 1% of the population) and it carries a separate risk for type III hyperlipoproteinemia, where the protein binds LDL poorly, triglycerides build up in tissue, and you get premature atherosclerosis. The best hand you can be dealt is probably a 2/3. You cannot pick your variant. You can find out which one you carry.
Why does an ancient gene increase Alzheimer's risk now?
APOE4 is the ancestral form, the oldest version in human evolution. APOE3 and APOE2 emerged later. For most of human evolution, APOE4 was the default, and it worked.
Our ancestors carried APOE4 while hunting large game across the savannah, long before agriculture, on a heavily animal-based diet. Then agriculture arrived. Diets shifted toward grains, legumes, and less animal protein. APOE3 and APOE2 spread, probably because they handled the new dietary load better. APOE4 stayed in 20 to 30% of the population, still optimized for handling lipid metabolism a particular way, which is to say still calibrated for more animal fat and protein.
Evolutionary biologists call this a mismatch. The gene stayed constant while the environment changed. The same pattern appears elsewhere: lactose tolerance varies by ancestry because dairy farming created specific selection pressures; the number of amylase gene copies you carry tracks how much starch your ancestors ate; the FADS genes that build enzymes for processing omega fatty acids differ by population based on marine fat in the ancestral diet. APOE may belong to the same category, a gene built for an animal-heavy diet now sitting in bodies eating a low-protein modern one.
How does APOE4 change the way your brain uses energy?
APOE4 changes brain energy metabolism. Yan and colleagues published a review in Translational Psychiatry showing that APOE4 brains tend to run hypermetabolic early in life, burning through glucose at a high rate, then transition to hypometabolism over time as glucose handling breaks down. The pattern echoes the link between diabetes and Alzheimer's, sometimes described as type 3 diabetes in the brain. I have written more about that energy failure in the critical aging window.
APOE4 handles cholesterol transport less efficiently and alters carnitine-dependent fat oxidation, which is the pathway that burns fat for fuel. This is where animal foods become relevant beyond protein content. They supply lipid-derived fuel precursors like creatine and carnitine, complete amino acid profiles, heme iron, and B12. The higher fat content can also generate ketones nutritionally.
The animal work fits. Mice with APOE4 upregulate the enzymes that burn ketones compared to non-APOE4 mice, and they perform better on a ketogenic diet than on a standard one. They appear wired to burn lipid-derived fuel. In humans, a supervised clinical case series found a ketogenic diet improved cognition in APOE4 carriers with mild Alzheimer's. The convergent signal points the same direction: reduce oxidative stress, supply quality fats and proteins, and an APOE4 brain has better fuel to work with. If you also have insulin resistance or elevated blood sugar, going protein-first adds satiety and blood sugar stability, so the move pays off in two ways.
Is this just the Mediterranean diet again?
Roughly, with a sharper edge. A 2025 Nature Medicine cohort showing the Mediterranean diet reduces dementia risk is still valid. What this APOE4 data suggests is that the quality of protein in that pattern may be carrying more of the weight than the polyphenols. The two findings sit together cleanly.
The practical shape is high-quality fats and proteins inside a Mediterranean framework. Do not fear unprocessed meat. Do fear processed meat. In the Swedish data, the benefit was specific to unprocessed animal protein and vanished when processed meat was isolated.
What should you actually do about your APOE status?
Start with the honest caveats. This is observational data, and people are notoriously bad at reporting what they eat. Conscientious Scandinavians may keep better records than average; Peak Brain runs an office in Sweden, and in my experience Swedes do what they say they will do and adhere to structure reliably, which may mean cleaner data. Either way, the signal is large, biologically plausible, and genotype-specific.
Genotype-specific is the key word, because it means you can act on your own status.
- Get tested. APOE status is a quick blood test. A week or two later you will know whether you are 2/2, 2/3, 3/4, 4/4, and so on. Knowing where you fall tells you where your specific risks live.
- If you carry APOE4: lean into quality protein, unprocessed meat, fish, and eggs. Your brain may run better on that fuel. Avoid processed meats. Prioritize omega-3s and DHA. Stay inside a Mediterranean pattern. Keep sugar low to limit the oxidative stress that hits APOE4 brains hardest.
- If you do not carry APOE4: the standard evidence-based advice holds. Mediterranean patterns, exercise, sleep, cognitive engagement, social connection. Maximizing protein appears to matter less for you. Strategic fasting and the other metabolic levers still apply.
The larger point is precision brain health. The idea that every brain needs the same diet reflects the same error as thinking every brain needs the same medication, the same neurofeedback protocol, or the same educational support. Your genes shape your risk. They do not set your outcome. Even 4/4 carriers, sitting at roughly ten times the background risk, can move that number through sugar reduction and, it now appears, protein quality.
Where brain mapping fits
Genetics is one window into your brain. Your EEG is another. At Peak Brain we map your brain and look for phenotypes that shape your resources for sleep, stress, attention, and mood, then teach you to move those through behavioral changes or neurofeedback training. If you want to see what your own brain looks like, QEEG brain mapping is the starting point, and you can read more about the phenotypes that drive your strengths and your struggles.
If you carry APOE4 and you have been steering toward a low-protein diet, this study gives you a concrete next step: get the blood test, confirm your genotype, and if you are positive, build your meals around unprocessed animal protein and quality fats inside a Mediterranean pattern while keeping sugar down. That is a change you can make this week, and it is one your specific genome appears to reward.